Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lopinavir pharmacokinetics with rifampicin and adjusted lopinavir/ritonavir dosing in South African adults with HIV
PACTR201206000159453Recruiting
- Sponsor
- Universal Cancer Technologies
- Start
- Jan 2009
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of lopinavir, ritonavir and rifampicin in human immunodeficiency virus infection (HIV) and Tuberculosis (TB), sponsored by Universal Cancer Technologies. Started Jan 2009; status: recruiting.
02
Drugs
lopinavirritonavirrifampicin
03
Conditions
human immunodeficiency virus infection (HIV)Tuberculosis (TB)
Beyond the preview
Go deeper on PACTR201206000159453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201206000159453.